FREQUENCY OF ADVERSE EVENTS ASSOCIATED WITH STATIN USE IN ROUTINE CLINICAL PRACTICE IN PAKISTANI POPULATION

Main Article Content

Muhammad Naeem Mengal, Sarfaraz Ali Zahid, Tariq Ashraf, Abida Munir Badini

Abstract

Objective: To evaluate the frequency of adverse events associated with statinsuse in routine clinical practice in Pakistani population.


Methodology: This cross sectional study was conducted at PNS SHIFA a tertiarycare hospital in Karachi, Pakistan from January 2015 to December 2015. Maleand female patients aged between 20-80 years who were taking statin for morethan 3 months and were willing to participate in the study were included.Demographic data like age, gender, medical morbidities e.g. diabetes mellitus ,hypertension, ischemic heart disease, cerebrovasculr accident , type and doseof statin and outcome variables like hepatitis, myalgia, myositis andrhabdomyolysis were recorded in a performa. Sample size was calculated usingopen Epi software. Data was entered and analyzed using SPSS version 21.0. P<0.05 was taken as significant.


Result: A total of 1350 patients aged between 20-80 years of age(Mean age55.7±10.2 years) were included in the study. There were 53.1 % male patients.Majority of patients (56.9%) were between 41-60 years of age group. About 58.2% patients had diabetes mellitus ,41.9 % had hypertension,26 % patients haddyslipidimia, 88%patients were with ischemic heart disease and 9.41%patientshad CVA. Rosuvastatin were prescribed to 56.3% patients, atorvastatin to 33%and simvastatin to 10.7% patients. Regarding the adverse effects, myalgias weremost frequently reported in 6.7 % patients; myositis was noted in 0.8 % patients,while rhabdomyolysis was not reported in any patient. Statin induced hepatitiswas noted in 2.9%.


Conclusion: There is overall a low frequency of adverse events associated withthe use of commonly prescribed statins in routine clinical practice. Further largescale studies are needed to validate our findings.

Article Details

Section
Articles